Protein-Restricted Diets Plus Keto/Amino Acids - A Valid Therapeutic Approach for Chronic Kidney Disease Patients

Journal of Renal Nutrition

Volumn 22, Issue 2 SUPPL., 2012, Pages

  Aparicio, Michel ^a   Bellizzi, Vincenzo ^b   Chauveau, Philippe ^c,d   Cupisti, Adamasco ^e   Ecder, Tevfik ^f   Fouque, Denis ^g   Garneata, Liliana ^h   Lin, Shanyan ⁱ   Mitch, William E ^j   Teplan, Vladimír ^k   Zakar, Gábor ^l   Yu, Xueqing ^m  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b S Giovanni di Dio e Ruggi d'Aragona Hospital   (Italy)

^c HÔPITAL PELLEGRIN   (France)

^d Aurad Aquitaine   (France)

^e UNIVERSITY OF PISA   (Italy)

^f ISTANBUL UNIVERSITY   (Turkey)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

ⁱ FUDAN UNIVERSITY   (China)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

^k INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^l Dialysis Center No 9   (Hungary)

^m SUN YAT SEN UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; OXOACID;

ACIDOSIS; ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; DIET THERAPY; HUMAN; INSULIN RESISTANCE; MALNUTRITION; METABOLISM; METHODOLOGY; MOUSE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEIN RESTRICTION; PROTEINURIA; RAT; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ACIDOSIS; AMINO ACIDS; ANIMALS; CARDIOVASCULAR DISEASES; DIET, PROTEIN-RESTRICTED; DIETARY SUPPLEMENTS; HUMANS; INSULIN RESISTANCE; KETO ACIDS; KIDNEY FAILURE, CHRONIC; MALNUTRITION; MICE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PROTEINURIA; RATS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 84863172664     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2011.09.005     Document Type: Article

References (86)

1. Chang J.H., Kim D.K., Park T.J., et al. Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low-protein diet. Nephrology 2009, 14:750-757.
2. Fouque D., Laville M. Low protein diets for chronic kidney disease in non- diabetic adults. Cochrane Database Syst Rev 2009, CD001892.
3. Ignace S., Fouque D., Arkouche W., Steghens J.P., Guebre-Egziabher F. Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients. Nephrol Dial Transplant 2009, 24:1685-1689.
4. D'Apolito M., Du X., Zong H., et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 2009, 120:203-213.
5. Gao X., Wu J., Dong Z., et al. A low-protein diet supplemented with ketoacids plays a more protective role against oxidative stress of rat kidney tissue with 5/6 nephrectomy than a low protein diet alone. Br J Nutr 2010, 103:608-616.
6. Di Iorio B.R., Cucciniello E., Martino R., Frallicciardi A., Tortoriello R., Struzziero G. Acute and persistent antiproteinuric effect of a low-protein diet in chronic kidney disease [in Italian]. G Ital Nefrol 2009, 26:608-615.
7. Brunori G., Viola B.F., Parrinello G., et al. Efficacy and safety of a very-low- protein diet when postponing dialysis in the elderly: a prospective randomized mulitcenter controlled study. Am J Kidney Dis 2007, 49:569-580.
8. Scalone L., Borghetti F., Brunori G., et al. Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients. Nephrol Dial Transplant 2010, 25:907-913.
9. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996, 7:198-207. Canada-USA (CANUSA) Peritoneal Dialysis Study Group.
10. Hasegawa T., Yoshimura A., Hirose M., et al. A strict low protein diet during the predialysis period suppresses peritoneal permeability at induction of peritoneal dialysis. Perit Dial Int 2009, 29:319-324.
11. Jiang N., Qian J., Sun W., et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial. Nephrol Dial Transplant 2009, 24:2551-2558.
12. Leal V.O., Delgado A.G., Leite M., Mitch W.E., Mafra D. Influence of renal function and diet on acid-base status in chronic kidney disease patients. J Ren Nutr 2009, 19:178-182.
13. de Brito-Ashurst I., Varagunam M., Raftery M.J., Yaqoob M.M. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 2009, 20:2075-2084.
14. Mitch M.W., Walser M., Steinman T.I., Hill S., Zeger S., Tungsanga K. The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 1984, 311:623-629.
15. Wesson D.E., Simon J. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Kidney Int 2009, 75:929-935.
16. Simon E.E., Hamm L.L. A basic approach to CKD. Kidney Int 2010, 77:567-569.
17. Phisitkul S., Khanna A., Simoni J. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int 2010, 77:617-623.
18. Wesson D.E., Nathan T., Rose T., Simoni J., Tran R.M. Dietary protein induce endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int 2007, 71:210-217.
19. Mircescu G., Garneata L., Stacu S.H., Capusa C. Effects of a supplemented hypoproteic diet in chronic kidney disease. J Ren Nutr 2007, 17:179-188.
20. Cupisti A., Licita R., Chisari C., et al. Skeletal muscle and nutritional assessment in chronic renal failure patients on a protein-restricted diet. J Intern Med 2004, 255:115-124.
21. Aparicio M., Chauveau P., de Precigout V., Bouche J.L., Lasseur C., Combe C. Nutrition and outcome on renal replacement therapy of patients with chronic renal failure treated with a supplemented very low-protein diet. J Am Soc Nephrol 2000, 11:708-716.
22. Hakim R.M., Lazarus J.M. Initiation of dialysis. J Am Soc Nephrol 1995, 6:1319-1328.
23. Pollock C.A., Ibels L.S., Zhu F.Y., et al. Protein intake in renal disease. J Am Soc Nephrol 1997, 8:777-783.
24. Mehrotra R., Nolph K.D. Treatment of advanced renal failure: low-protein diets or timely initiation of dialysis. Kidney Int 2000, 58:1381-1388.
25. Tom K., Young V.R., Chapman T., Masud T., Akpele L., Maroni B.J. Long-term adaptive responses to dietary protein restriction in chronic renal failure. Am J Physiol 1995, 268(4 pt 1):E668-E677.
26. Chauveau P., Barthe N., Rigalleau V., et al. Outcome of nutritional status and body composition of uremic patients on a very low-protein diet. Am J Kidney Dis 1999, 34:500-507.
27. Chauveau P., Vendrely B., El Haggan W., et al. Body composition of patients on a very low-protein diet: a two-year survey with DEXA. J Ren Nutr 2003, 13:282-287.
28. Chauveau P., Couzi L., Vendrely B., et al. Long-term outcome on renal replacement therapy in patients who previously received a keto-acid supplemented very-low-protein diet. Am J Clin Nutr 2009, 90:969-974.
29. Levey A.S., Adler S., Caggiula A.W., et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis 1996, 27:652-663. Modification of Diet in Renal Disease Study Group.
30. Coresh J., Walser M., Hill S. Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995, 6:1379-1385.
31. Menon V., Kopple J.D., Wang X., et al. Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 2009, 53:208-217.
32. Bellizzi V., Di Iorio B.R., De Nicola L., et al. Very low-protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int 2007, 71:245-251. ERIKA Study-Group.
33. Bellizzi V., De Nicola L., Di Iorio B. Restriction of dietary protein and long-term outcomes in patients with CKD. Am J Kidney Dis 2009, 54:183-184.
34. Cianciaruso B., Pota A., Bellizzi V., et al. Effect of a low- versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. Am J Kidney Dis 2009, 54:1052-1061.
35. Bellizzi V., Chiodini P., Cupisti A., et al. Very low-protein diet plus ketoanalogs (sVLPD) during CKD and survival during renal replacement therapy (RRT): a controlled, cohort study. J Am Soc Nephrol 2010, 21:664.
36. Mandayam S., Mitch W.E. Dietary protein restriction benefits patients with chronic kidney disease. Nephrology 2006, 11:53-57.
37. Fouque D., Wang P., Laville M., Boissel J.P. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000, 15:1986-1992.
38. Mitch W.E. Dietary protein restriction in chronic renal failure: nutritional efficacy, compliance, and progression of renal insufficiency. J Am Soc Nephrol 1991, 2:823-831.
39. Fürst P., Stehle P. What are the essential elements needed for the determination of amino acid requirements in humans?. J Nutr 2004, 134(suppl):S1558-S1565.
40. McCann L., Feldman C., Hornberger J., et al. Effect of intradialytic parenteral nutrition on delivered Kt/V. Am J Kidney Dis 1999, 33:1131-1135.
41. Tuttle K.R., Johnson E.C., Cooney S.K., et al. Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int 2005, 67:953-968.
42. Hiroshige K., Sonta T., Suda T., Kanegae K., Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic hemodialysis. Nephrol Dial Transplant 2001, 16:1856-1862.
43. Burrowes J.D., Larive B., Chertow G.M., et al. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant 2005, 20:2765-2774.
44. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005, 81:543-554.
45. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
46. Iseki K., Ikemiya Y., Iseki C., Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003, 63:1468-1474.
47. Walls J. Relationship between proteinuria and progressive renal disease. Am J Kidney Dis 2001, 37(suppl 2):S13-S16.
48. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782.
49. Miettinen H., Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996, 27:2033-2039.
50. de Zeeuw D., Remuzzi G., Parving H.H., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110:921-927.
51. Hostetter T.H., Olson J.L., Rennke H.G., Venkatachalam M.A., Brenner B.M. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981, 241:F85-F93.
52. Klahr S., Levey A.S., Beck G.J., Caggiula A.W., Hunsicker L., Kusek J.W. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 1994, 330:877-884. Modification of Diet in Renal Disease Study Group.
53. Chauveau P., Combe C., Rigalleau V., Vendrely B., Aparicio M. Restricted protein diet is associated with decrease in proteinuria: consequences on the progression of renal failure. J Renal Nutr 2007, 17:250-257.
54. Teplan V., Schuck O., Knotek A., Hajny J., Horackova M., Kvapil M. Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study. Am J Kidney Dis 2003, 41(suppl):S26-S30.
55. Pedrini M.T., Levey A.S., Lau J.L., Chalmers T.C., Wang P.H. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta analysis. Ann Intern Med 1996, 124:627-632.
56. Esposito K., Marfella R., Ciotola M., et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
57. Lopez-Garcia E., Schulze M.B., Fung T.T., et al. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004, 80:1029-1035.
58. Cupisti A., Ghiadoni L., D'Alessandro C., et al. Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol Dial Transplant 2007, 22:229-234.
59. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003, 349:1027-1035.
60. Rigo F., Gherardi S., Galderisi M., et al. The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in nonischemic dilated cardiomyopathy. Eur Heart J 2006, 27:1319-1323.
61. Yokoyama I., Momomura S., Ohtake T., et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997, 30:1472-1477.
62. Pisoni R., Sayathum S., Young E., et al. Predictors of hyperphosphatemia and its association with cardiovascular deaths and hospitalization in chronic hemodialysis patients: international results from the DOPPS. Nephrol Dial Transplant (Am) 2003, 18(suppl 4):678.
63. Kestenbaum B. Phosphate metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 2007, 20:286-294.
64. Tonelli M., Sacks F., Pfeffer M., Gao Z., Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005, 112:2627-2633. Cholesterol and Recurrent Events Trial Investigators.
65. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007, 167:879-885.
66. Karalis M., Murphy-Gutekunst L. Patient education. Enhanced foods: hidden phosphorus and sodium in foods commonly eaten. J Ren Nutr 2006, 16:79-81.
67. Benini O., D'Alessandro C., Gianfaldoni D., Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr 2011, 21:303-308.
68. Sherman R.A., Mehta O. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 2009, 54:18-23.
69. Sullivan C., Sayre S.S., Leon J.B., et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009, 301:629-635.
70. Cupisti A., Comar F., Benini O., et al. Effect of boiling on dietary phosphate and nitrogen intake. J Ren Nutr 2006, 16:36-40.
71. Bombas A., Stein-Oakley A.N., Baxter K., Thomson N.M., Jablonski P. Development of injury in a rat model of chronic renal allograft rejection: effect of dietary protein restriction. Transpl Int 1999, 12:18-26.
72. Biesenbach G., Zazgornik J., Janko O., Hubmann R., Syré G. Effect of mild dietary protein restriction on urinary protein excretion in patients with renal transplant fibrosis. Wien Med Wochenschr 1996, 146:75-78.
73. Teplan V., Valkovsky I., Teplan V., Stollova M., Vyhnanek F., Andel M. Nutritional Consequences of renal transplantation. J Renal Nutr 2009, 19:95-100.
74. Dillon E.L., Sheffield-Moore M., Paddon-Jones D., et al. Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin Endocrinol Metab 2009, 94:1630-1637.
75. Teplan V., Maly J., Gürlich R., Teplan V., Kudla M., Pitha J., Racek J., Haluzik M., Senolt L., Stollová M. Muscle and fat metabolism in obesity after kidney transplantation: no effect of peritoneal dialysis or hemodialysis. J Ren Nutr 2012, 22:166-170.
76. Teplan V, Hubáček J, Mahrová A, Štollová M. Better results of keto/amino acids and exercise intervention on muscle/fat tissue metabolism in peritoneal dialysis patients after kidney transplantation. ESPEN. In press. Abs n°:ESPEN2010-ABS-430;PP093. https://b-com.mci-group.com/Abstract.
77. Wang A.Y., Woo J., Wang M., et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005, 20:396-403.
78. Liao C.T., Chen Y.M., Shiao C.C., et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009, 24:2909-2914.
79. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15:458-482.
80. Ohkawa S., Kaizu Y., Odamaki M., et al. Optimal dietary protein requirement in nondiabetic maintenance hemodialysis patients. Am J Kidney Dis 2004, 43:454-463.
81. Knefati Y., Wone C., Aparicio M. Protein malnutrition of CAPD patients could be treated by oral mixtures of ketoacids and essential amino acids (KA/AA). Kidney Int 1989, 27(suppl):303.
82. Mahmoud M.D., Bouché V., Collin P. Effets des céto-analogues des acides aminés essentiels avec ou sans restriction protidique associée sur le métabolisme phospho-calcique des patients hémodialysés: étude prospective randomisée en essai croisé. Néphrologie 1988, 9:83-87.
83. Macia M., Coronel F., Navarro J.F., et al. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD. Clin Nephrol 1997, 48:181-184.
84. Schober H.J., Ostsen B., Panicke U., Zingler R., Abendroth K., Schmicker R. Ketoanaloga essentieller Aminosäuren bessern die renale Osteopathie bei Dialysepatienten. Z Klin Med 1991, 46:1197-1200.
85. Li H., Long Q., Shao C., et al. Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients. Blood Purif 2011, 31:33-40.
86. National Kidney Foundation-kidney disease outcomes quality initiative. Am J Kidney Dis 2002, 39(suppl 1):S1-S222. NFK-K/DOQI Guidelines.